文献速递临床试验与 GCP医学教育与科研方法

开发面向每个家庭的更好研究互动(BRIEF)干预以支持新生儿临床试验招募:一种干预映射指导的方法

Development of the Better Research Interactions for Every Family (BRIEF) intervention to support recruitment for neonatal clinical trials: an intervention mapping guided approach.
PubMed 文献 · Trials · 2024-09-12

研究旨在开发BRIEF干预,以改善新生儿临床试验招募体验并提高参与度,重点关注少数族裔人群。采用干预映射(IM)六步骤,组建家长和专家小组,识别低招募率的关键决定因素,选择三种理论和方法,开发包括自学预习和单次面对面会议的干预组件,并以达依泊汀α联合缓慢释放静脉铁试验作为试点合作研究。

要点

  • BRIEF干预针对研究团队成员,旨在改善所有父母尤其是少数族裔人群的招募体验。
  • 采用干预映射六步骤系统开发,组建家长小组和专家小组提供指导。
  • 选择社会认知理论、信息处理理论和跨理论模型三种理论指导干预设计。

核心结论

  • 本文分享了为改善新生儿临床试验招募流程而创建面向研究团队成员的干预的原理和过程。
  • 该方法可为旨在改善新生儿临床试验招募的人员以及可能考虑在类似情境中使用干预映射的人员提供参考。

研究设计与样本

  • 采用干预映射(IM)指导干预开发的所有步骤,IM是一个规划框架,提供系统过程和详细方案用于干预开发、实施和评估的逐步决策。
  • 在美国新生儿研究背景下开发BRIEF干预,其两个总体目标是改善所有父母的招募体验(重点关注少数族裔人群)和提高参与度(重点关注减少研究参与差异)。

主要发现

  • 步骤1:组建两个利益相关者小组(家长小组和专家小组),通过近期系统综述、团队收集的实证数据和与小组的咨询,识别低招募率的关键决定因素(障碍和促进因素)以及研究团队成员作为变革推动者。
  • 步骤2:迭代完善关键因素列表,并将行为改变的决定因素与绩效目标关联。
  • 步骤3:选择三种理论(社会认知理论、信息处理理论和跨理论模型),以及适合人群(研究团队成员)和情境(繁忙的研究NICU团队)的实践应用方法。
  • 步骤4:开发和优化干预组件,包括自学预习和单次面对面会议。
  • 步骤5:确定达依泊汀α联合缓慢释放静脉铁试验作为试点BRIEF的合作研究。

关键数值与推荐

  • BRIEF干预的两个总体目标:改善所有父母的招募体验(重点关注少数族裔人群)和提高参与度(重点关注减少研究参与差异)。
  • 干预组件包括自学预习和单次面对面会议。
  • 评估计划包含五个不同层次的结果。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recruitment for neonatal clinical trials can be particularly challenging. Low enrollment rates bias the research population and decrease generalizability of findings. We identified a critical need for an intervention to improve how researchers recruit for neonatal clinical trials. Working within the US neonatal research context, we developed the Better Research Interactions for Every Family (BRIEF) Intervention, which had two overarching goals: to improve the recruitment experience for all parents, focusing on minoritized populations, and to increase participation, focusing on decreasing disparities in research participation. METHODS: We used intervention mapping (IM) to guide all steps of intervention development. IM is a planning framework that provides a systematic process and detailed protocol for step-by-step decision-making for intervention development, implementation, and evaluation. RESULTS: We performed IM's six steps. In step 1, we convened two stakeholder groups, a parent panel and an expert panel, who provided guidance through development of all BRIEF components. Through a recent systematic review, empirical data collected by our team, and consultations with the panels, we identified key determinants (barriers and facilitators) of low enrollment rates and research team members as change agents. In step 2, we iteratively refined our list of key factors to include and linked determinants of behavior changes to these performance objectives. In step 3, we chose three theories (social cognitive theory, theory of information processing, and the trans-theoretical model), methods from identified practical applications suitable for the population (research team members) and the context (busy research NICU teams). In step 4, we developed and refined the intervention components, including self-guided pre-work and a single in-person session. In step 5, we identified the Darbepoetin plus slow-release intravenous iron trial as our partner study in which to pilot BRIEF. In step 6, we developed a multi-stage evaluation plan that included five distinct levels of outcomes. CONCLUSIONS: This manuscript shares our rationale and processes for the creation of a research team member-facing intervention aiming to improve recruitment processes for neonatal clinical trials. Our approach can inform those aiming to improve recruitment for neonatal clinical trials and those who may be considering use of IM within similar contexts.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Weiss EM, Gray MM, Ko LK, et al. Development of the Better Research Interactions for Every Family (BRIEF) intervention to support recruitment for neonatal clinical trials: an intervention mapping guided approach. Trials. 2024. PMID: 39267164. doi:10.1186/s13063-024-08446-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。